We use cookies on our website to make it clear, useful and reliable.In order to achieve this and to provide certain personalised features we store a small amount of data about you. To learn more visit Cookies: How we use the information on our website. By navigating from the front page to other sections of our website, you are consenting to information being stored.
A new vaccine study which will assess the safety and efficacy of a vaccine will will target multiple variants of the COVID-19-causing Sars-CoV-2 virus - including the current dominant variant Omicron.
By NIHR Wellcome King's Clinical Research Facility at 13 Apr 2022
The NIHR Maudsley Biomedical Research Centre (BRC) is part of the NIHR and hosted by South London and Maudsley NHS Foundation Trust in partnership with King's College London. We are part of King’s Health Partners Academic Health Sciences Centre.
© NIHR Maudsley Biomedical Research Centre 2025 | All rights reserved.
